πŸ‡ΊπŸ‡Έ FDA
Patent

US 8759332

Hepatitis C virus inhibitors

granted A61KA61K38/21A61P

Quick answer

US patent 8759332 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/21, A61P, A61P31/14